These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The Ca2+-mobilizing potency of alpha-thrombin and thrombin-receptor-activating peptide on human platelets -- concentration and time effects of thrombin-induced Ca2+ signaling. Heemskerk JW; Feijge MA; Henneman L; Rosing J; Hemker HC Eur J Biochem; 1997 Oct; 249(2):547-55. PubMed ID: 9370366 [TBL] [Abstract][Full Text] [Related]
25. Rac1 is essential for phospholipase C-gamma2 activation in platelets. Pleines I; Elvers M; Strehl A; Pozgajova M; Varga-Szabo D; May F; Chrostek-Grashoff A; Brakebusch C; Nieswandt B Pflugers Arch; 2009 Mar; 457(5):1173-85. PubMed ID: 18704487 [TBL] [Abstract][Full Text] [Related]
26. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Krishnamurthi S; Joseph S; Kakkar VV Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746 [TBL] [Abstract][Full Text] [Related]
27. The human megakaryocytic cell line UT-7/TPO expresses functional platelet agonist signals mediated through GPVI and thromboxane receptor. Kawaguchi T; Hashimoto R; Yokota H Cell Biol Int; 2010 Sep; 34(9):943-9. PubMed ID: 20522022 [TBL] [Abstract][Full Text] [Related]
28. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP. Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902 [TBL] [Abstract][Full Text] [Related]
29. Epinephrine correction of impaired platelet thromboxane receptor signaling. Dunlop PC; Leis LA; Johnson GJ Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1760-71. PubMed ID: 11078690 [TBL] [Abstract][Full Text] [Related]
30. The intracellular action of sphingosine 1-phosphate in GPVI-mediated Ca2+ mobilization in platelets. Ohmori T; Yatomi Y; Osada M; Ozaki Y Thromb Res; 2005; 115(5):409-15. PubMed ID: 15733975 [TBL] [Abstract][Full Text] [Related]
31. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409 [TBL] [Abstract][Full Text] [Related]
32. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood. Sanderson HM; Heptinstall S; Vickers J; Lösche W Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830 [TBL] [Abstract][Full Text] [Related]
33. Glycoprotein VI-mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP. Quinton TM; Ozdener F; Dangelmaier C; Daniel JL; Kunapuli SP Blood; 2002 May; 99(9):3228-34. PubMed ID: 11964287 [TBL] [Abstract][Full Text] [Related]
34. A three-dimensional multiscale model for the prediction of thrombus growth under flow with single-platelet resolution. Shankar KN; Zhang Y; Sinno T; Diamond SL PLoS Comput Biol; 2022 Jan; 18(1):e1009850. PubMed ID: 35089923 [TBL] [Abstract][Full Text] [Related]
35. Role of the recombinant non-integrin platelet collagen receptor P65 on platelet activation induced by convulxin. Francischetti IM; Chiang TM; Guimarães JA; Bon C Biochem Biophys Res Commun; 2000 Apr; 270(3):932-5. PubMed ID: 10772928 [TBL] [Abstract][Full Text] [Related]
36. Development of a high-throughput ELISA assay for platelet function testing using platelet-rich plasma or whole blood. Salles I; Broos K; Fontayne A; Szántó T; Ruan C; Nurden AT; Vanhoorelbeke K; Deckmyn H Thromb Haemost; 2010 Aug; 104(2):392-401. PubMed ID: 20508902 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets. Armstrong RA; Humphrey PP; Lumley P Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228 [TBL] [Abstract][Full Text] [Related]
38. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
39. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha. Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612 [TBL] [Abstract][Full Text] [Related]
40. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]